Cellares stock

Cellares Stock

HealthTech

Looking to sell Cellares stock or options?

Founded: 2019Funding to Date: $356Mhttps://www.cellares.com

Cellares is a dedicated Integrated Development and Manufacturing Organization, striving to expedite the availability of life-saving cell therapies for patients. This company is at the forefront of developing and implementing integrated cell therapy manufacturing technologies. This not only accelerates the pace of drug development but also facilitates manufacturing scale-out, thereby fulfilling global patient demand. Cellares works in collaboration with academic institutions, biotech firms, and pharmaceutical companies, facilitating faster drug development.

Investors Include:

Koch Disruptive Technologies, DFJ Growth, Skyviews Life Science, 8VC, Eclipse Ventures, Bristol-Myers Squibb, Trinity Capital, Decheng Capital, EcoR1 Capital, Willett Advisors.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more